- ISIN
- US90184D1000
- CUSIP
- 90184D100
- Sector
- Healthcare
- Industry
- Diagnostics & Research
- IPO Date
- Oct 31, 2018
Highlights
- Market Cap
- $5.26B
- Enterprise Value
- $5.24B
- EPS (TTM)
- -$1.33
- Total Revenue (TTM)
- $409.48M
- Gross Profit (TTM)
- $213.23M
- EBITDA (TTM)
- -$58.23M
- Year Range
- $23.30 - $89.71
- Target Price
- $55.67
- ROA (TTM)
- -12.02%
- ROE (TTM)
- -17.86%
Share Price Chart
Loading charts...
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
TWST Performance Chart
Twist Bioscience Corporation (TWST) is up 168.5% since the beginning of the year. At $85 per share, TWST is trading 5.1% below its 52-week high of $90. Investors who bought $1,000 worth of TWST shares 5 years ago would now be looking at an investment worth $709.
Loading charts...
Returns By Period
Twist Bioscience Corporation (TWST) has returned 168.51% so far this year and 145.87% over the past 12 months.
Twist Bioscience Corporation
- 1D
- -2.73%
- 1M
- 40.61%
- YTD
- 168.51%
- 6M
- 142.93%
- 1Y
- 145.87%
- 3Y*
- 70.18%
- 5Y*
- -6.65%
- 10Y*
- —
Benchmark (S&P 500 Index)
- 1D
- -0.37%
- 1M
- -0.01%
- YTD
- 9.16%
- 6M
- 8.64%
- 1Y
- 25.22%
- 3Y*
- 19.78%
- 5Y*
- 11.99%
- 10Y*
- 13.88%
TWST Monthly Returns History
Based on dividend-adjusted daily data since Oct 31, 2018, TWST's average daily return is +0.22%, while the average monthly return is +4.00%. At this rate, an investment would double in approximately 1.5 years.
Historically, 54% of months were positive and 46% were negative. The best month was Nov 2018 with a return of +89.0%, while the worst month was Apr 2022 at -41.6%. The longest winning streak lasted 10 consecutive months, and the longest losing streak was 6 months.
On a daily basis, TWST closed higher 51% of trading days. The best single day was Nov 9, 2018 with a return of +31.6%, while the worst single day was Mar 16, 2020 at -22.9%.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | 29.48% | 14.24% | 1.28% | 23.00% | 14.41% | 27.37% | 168.51% | ||||||
| 2025 | 12.70% | -25.87% | 1.13% | -2.39% | -23.54% | 25.56% | -8.75% | -19.66% | 4.34% | 16.88% | -2.68% | -0.91% | -31.74% |
| 2024 | -12.10% | 21.27% | -12.67% | -8.98% | 34.17% | 17.61% | 13.25% | -22.52% | 4.49% | -10.67% | 21.85% | -5.51% | 26.07% |
| 2023 | 20.50% | -32.17% | -22.51% | -17.24% | 21.39% | 35.05% | 18.96% | -9.65% | -7.87% | -22.21% | 52.60% | 53.26% | 54.81% |
| 2022 | -23.22% | -5.86% | -11.73% | -41.60% | 18.03% | 2.70% | 25.11% | -8.28% | -12.16% | -6.84% | -16.69% | -12.94% | -69.23% |
| 2021 | 16.46% | -16.35% | -10.01% | 8.34% | -20.03% | 24.17% | -7.65% | -8.00% | -5.51% | 11.06% | -19.61% | -18.96% | -45.23% |
Benchmark Metrics
Twist Bioscience Corporation has an annualized alpha of 31.57%, beta of 1.80, and R2 of 0.21 versus S&P 500 Index. Calculated based on daily prices since October 31, 2018.
- This stock captured 195.80% of S&P 500 Index gains and 134.82% of its losses - amplifying both gains and losses, but participating more in upside than downside.
- R2 of 0.21 means this stock moves largely independently of S&P 500 Index - capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.
- Alpha
- 31.57%
- Beta
- 1.80
- R²
- 0.21
- Upside Capture
- 195.80%
- Downside Capture
- 134.82%
Return for Risk
Risk / Return Rank
TWST ranks 86 for risk / return — in the top 86% of stocks on our site. This means strong returns relative to risk — exactly what professional investors look for. Well-suited for investors who want to maximize return per unit of risk.
Return / Risk — by metrics
The table below present risk-adjusted performance metrics for Twist Bioscience Corporation (TWST) and compare them to S&P 500 Index.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| TWST | Benchmark | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +0.17 | ||
| Sortino ratioReturn per unit of downside risk | -0.01 | ||
| Omega ratioGain probability vs. loss probability | 1.31 | 1.37 | -0.05 |
| Calmar ratioReturn relative to maximum drawdown | 3.84 | 2.78 | +1.05 |
| Martin ratioReturn relative to average drawdown | 8.14 | 12.44 | -4.30 |
Dividends
Dividend History
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Loading charts...
Worst Drawdowns
The table below displays the maximum drawdowns of the Twist Bioscience Corporation. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Twist Bioscience Corporation was 94.48%, occurring on May 2, 2023. The portfolio has not yet recovered.
The current Twist Bioscience Corporation drawdown is 59.05%.
Related event | Drawdown | Fall | Recovery | Underwater |
|---|---|---|---|---|
2023 bear market2023 | -94.48%May 2023 | 2y 3mo | — | 5y 5moJan 2021 - now |
Rate-hike selloffLate 2018 | -47.55%Dec 2018 | 14d | 4mo 3d | 4mo 17dDec 2018 - Apr 2019 |
COVID crash2020 | -43.93%Mar 2020 | 9d | 1mo 19d | 1mo 28dMar 2020 - May 2020 |
2020 bear market2020 | -38.66%Jan 2020 | 5mo 5d | 2mo 4d | 7mo 9dJul 2019 - Mar 2020 |
2019 bear market2019 | -34.52%May 2019 | 12d | 2mo 23d | 3mo 5dApr 2019 - Jul 2019 |
Drawdown Indicators
| TWST | Benchmark | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -94.48% | -56.78% | -37.70% |
Max Drawdown (1Y)Largest decline over 1 year | -38.24% | -9.10% | -29.14% |
Max Drawdown (3Y)Largest decline over 3 years | -58.97% | -18.90% | -40.07% |
Max Drawdown (5Y)Largest decline over 5 years | -91.54% | -25.43% | -66.11% |
Max Drawdown (10Y)Largest decline over 10 years | — | -33.92% | — |
Current DrawdownCurrent decline from peak | -59.05% | -1.80% | -57.25% |
Average DrawdownAverage peak-to-trough decline | -58.15% | -10.71% | -47.44% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 17.99% | 2.03% | +15.96% |
Volatility
Volatility Chart
The chart below shows the rolling one-month volatility.
Loading charts...
Financials
Financial Performance
The chart below illustrates the trends in the financial health of Twist Bioscience Corporation over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.
Valuation
The Valuation section provides an overview of how Twist Bioscience Corporation is priced in the market compared to other companies in the Diagnostics & Research industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.
PS Ratio
This chart shows the Price-to-Sales (P/S) ratio for TWST relative to other companies in the Diagnostics & Research industry. Currently, TWST has a P/S ratio of 12.7. This P/S ratio is high relative to other companies in the industry. It could mean the stock is overvalued, or that investors expect strong future growth and profitability.
PB Ratio
The chart illustrates the Price-to-Book (P/B) ratio for TWST in comparison with other companies in the Diagnostics & Research industry. Currently, TWST has a P/B value of 11.5. This P/B ratio is higher than most companies in the industry. It may suggest the stock is overvalued or that investors expect the company to generate high returns on its assets.
Income Statement
| TTM | |
|---|---|
Revenue | — |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
Operating Expenses | — |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
Income | — |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |
Build a portfolio with TWST
Add Twist Bioscience Corporation to a portfolio and analyze allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Analyzer with TWST